These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33842215)

  • 1. Continuous-flow left ventricular assist device versus orthotopic heart transplantation in adults with heart failure: a systematic review and meta-analysis.
    Zhang B; Guo S; Ning J; Li Y; Liu Z
    Ann Cardiothorac Surg; 2021 Mar; 10(2):209-220. PubMed ID: 33842215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis.
    Theochari CA; Michalopoulos G; Oikonomou EK; Giannopoulos S; Doulamis IP; Villela MA; Kokkinidis DG
    Ann Cardiothorac Surg; 2018 Jan; 7(1):3-11. PubMed ID: 29492379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.
    McNamara N; Narroway H; Williams M; Brookes J; Farag J; Cistulli D; Bannon P; Marasco S; Potapov E; Loforte A
    Ann Cardiothorac Surg; 2021 Mar; 10(2):186-208. PubMed ID: 33842214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow.
    Daneshmand MA; Krishnamoorthy A; Samsky MD; Felker GM; Pura JA; Lokhnygina Y; Hernandez AF; Rosenberg PB; Blue LJ; Schroder JN; Rogers JG; Milano CA; Patel CB
    Am J Cardiol; 2015 Aug; 116(4):573-9. PubMed ID: 26092273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor.
    Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT
    J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Ammirati E; Brambatti M; Braun OÖ; Shah P; Cipriani M; Bui QM; Veenis J; Lee E; Xu R; Hong KN; Van de Heyning CM; Perna E; Timmermans P; Cikes M; Brugts JJ; Veronese G; Minto J; Smith S; Gjesdal G; Gernhofer YK; Partida C; Potena L; Masetti M; Boschi S; Loforte A; Jakus N; Milicic D; Nilsson J; De Bock D; Sterken C; Van den Bossche K; Rega F; Tran H; Singh R; Montomoli J; Mondino M; Greenberg B; Russo CF; Pretorius V; Liviu K; Frigerio M; Adler ED
    Int J Cardiol; 2021 Feb; 324():122-130. PubMed ID: 32950592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
    Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Continuous Flow Left Ventricular Assist Device on Heart Transplant Candidates: A Multi-State Survival Analysis.
    Carrozzini M; Bottio T; Caraffa R; Bejko J; Bifulco O; Guariento A; Lombardi CM; Metra M; Azzolina D; Gregori D; Fedrigo M; Castellani C; Tarzia V; Toscano G; Gambino A; Jorgji V; Ferrari E; Angelini A; Gerosa G
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients.
    Miller RJH; Moayedi Y; Sharma A; Haddad F; Hiesinger W; Banerjee D
    ASAIO J; 2020 Apr; 66(4):394-398. PubMed ID: 31192848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.